| 0 | ℹ |
Pomalidomide plus bortezomib and dexamethasone for newly diagnosed multiple myeloma with renal impairment: Randomized phase II study (POM-MM-003).
(linkinghub.elsevier.com)
|
Cell Med 2026-09-09 | #myeloma #clinical trial #chemotherapy #nephropathy #hematology |